The Medicare Merit-based Incentive Payment System (MIPS) offers healthcare professionals a specialty-focused reporting option through MIPS Value Pathways (MVPs). This framework connects the four MIPS performance categories (Quality, Cost, Improvement Activities, and Promoting Interoperability) around a specific clinical specialty, condition, or patient population. For the 2027 performance year, the Centers for Medicare & Medicaid Services (CMS) has finalized three new pathways, bringing the total to 30, introduced a designated MIPS Core Measure requirement, and updated existing quality measures and reporting activities.
The CY 2027 Physician Fee Schedule Final Rule, released on November 4, 2026, also updates Promoting Interoperability and extends traditional MIPS reporting through the CY 2030 performance period, with MVP-only reporting beginning in 2031 for applicable clinicians. CMS followed on November 6, 2026 with the 2027 Finalized MVPs Guide, which lists the measures, cost measures, and Improvement Activities for every pathway. This guide by Proactive Healthcare Services walks through the finalized requirements, all 30 pathways, core measure rules, scoring, and practical preparation steps, so practices can choose a pathway and keep accurate CMS quality reporting.
How MIPS Value Pathways Work
Traditional MIPS is a build-your-own reporting model. Clinicians select six quality measures, choose Improvement Activities separately, report Promoting Interoperability on their own track, and have CMS calculate Cost performance from Medicare claims. The four performance categories are scored separately before they combine into the final MIPS score.
An MVP connects these components. CMS defines the pathway, and the measures and activities inside it relate to a specialty, clinical condition, patient population, or episode of care. The goal is reporting that is more relevant to the care clinicians deliver and fairer comparisons among providers with similar clinical responsibilities.
A few terms matter:
- Performance categories: Quality, Cost, Improvement Activities, and Promoting Interoperability. Together they determine the final score.
- Pathway: The specific MVP an eligible clinician, group, or subgroup registers for and reports.
- MIPS Core Measure: A quality measure CMS designates as core within a pathway for the 2027 reporting requirement.
- Subgroup: A subset of a larger multispecialty group that reports its own MVP.
- Foundational layer: The part of every MVP that is consistent across pathways: two population health measures and the Promoting Interoperability measures. CMS calculates both population health measures from administrative claims: Q479 (Hospital-Wide Readmission) and Q484 (Admission Rates for Patients with Multiple Chronic Conditions). If the applicable case minimum is met, CMS assigns the higher-scoring measure to the MVP’s Quality score. Practices do not select or submit these two measures themselves.
Two clarifications prevent common mistakes. An MVP is not a specialty measure set: a measure set is only a list of quality measures, while an MVP ties together all four categories and requires advance registration. And not every specialty has a dedicated pathway. Some pathways focus on a specialty, others on a condition, patient population, or care setting.
CMS says the MVP inventory covers about 98% of clinicians. Availability does not mean every pathway fits every practice, so clinical applicability and measure availability still need to be tested.
What Is New in MIPS Value Pathways for 2027?
The table separates the finalized 2027 changes from the 2026 rules they replace. For the full list of program changes outside MVPs, see our overview of the major MIPS changes for 2027.
| Policy area | 2026 requirements | Finalized 2027 requirements | Practical impact |
| MVP inventory | 27 MVPs | Three new MVPs: Diabetic Disease, Hypertension, and Hospitalist, bringing the total to 30. All 27 existing MVPs were modified. | Reevaluate available pathways. |
| Quality measures | Four measures in an MVP, including an outcome measure or high-priority measure if no outcome measure applies. | Outcome and high-priority measure requirement removed. At least one designated MIPS Core Measure is required. Inventory reduced from 190 to 180 measures. | Review core measure applicability and pathway specifications. |
| Improvement Activities | Existing activity inventory | Six activities added, five modified, and 11 removed. | Confirm that planned activities remain available. |
| Promoting Interoperability | Security Risk Analysis requirement and previously scheduled Electronic Prior Authorization requirement. | Security Risk Analysis removed from MIPS PI beginning in 2027. Electronic Prior Authorization becomes an optional 10-point bonus measure in 2027 and mandatory in 2028. A separate prescription drug measure also becomes mandatory in 2028. | Review EHR capabilities and update reporting workflows. |
| Cost measures | CMS calculates costs using claims. | No new cost measure inventory was finalized. Operational maintenance updates continue. | Review pathway-specific cost exposure. |
| Individual participation | Available | Continues. | No major change. |
| Group participation | Single-specialty groups and qualifying small multispecialty groups. | Continues. Larger multispecialty groups must use subgroups or report as individuals. | Establish appropriate reporting structures. |
| Subgroup reporting | Available through MVPs. | Continues. | Prepare subgroup-level data collection. |
| Virtual groups | Traditional MIPS only. | MVP participation becomes available beginning with CY 2029. | No virtual group MVP reporting in 2027 or 2028. |
| Scoring | 30/30/15/25 category weights and a 75-point threshold. | Default weights remain unchanged. The threshold remains 75 through CY 2028. | Continue planning around the existing scoring framework. |
The final rule also changed the proposal CMS released in July 2026. CMS originally proposed ending traditional MIPS after CY 2028. The final rule moved that to after CY 2030, so older articles citing 2029 as the start of mandatory MVPs describe the proposal, not the final policy.
The three new pathways at a glance
The 2027 Finalized MVPs Guide lists the following for the new pathways.
| New pathway | Specialties CMS lists | Core measures | Cost measures attached |
| Diabetic Disease | Primary care, endocrinology, ophthalmology, podiatry, and nonphysician practitioners | Q001, Q128, Q317, Q488 | COST_D_1 (Diabetes) and TPCC_1 (Total Per Capita Cost) |
| Hospitalist | Hospitalists and nonphysician practitioners | Q005, Q008, Q047 | MSPB_1 (Medicare Spending Per Beneficiary Clinician) |
| Hypertension | Cardiology, family medicine, geriatrics, internal medicine, nutrition and dietetics, preventive medicine, and nonphysician practitioners | Q128, Q226, Q236 | TPCC_1 (Total Per Capita Cost) |
The Diabetic Disease and Hypertension pathways both include the new Improvement Activity Lifestyle Approaches to Diabetes Remediation (IA_AHW_5), and the Hypertension pathway adds the new LDL-C monitoring and management measure (Q517).
The 2027 MIPS Core Measure Requirement
The core measure requirement is the most important new quality rule for 2027. CMS identified 77 quality measures as MIPS core measures for the 2027 performance period, and each MVP lists its own core measures in the 2027 Finalized MVPs Guide. This section is the one place the full rule is explained. For the measure list, benchmarks, and traditional MIPS selection guidance, see our 2027 MIPS core measures guide.
The rule is not identical across reporting options:
| Situation | Traditional MIPS | MVP |
| Quality measures reported | 6 | 4 |
| Core measure requirement | At least 1 core measure, counted as one of the 6. Any core-designated measure in the inventory qualifies, except as CMS notes. | At least 1 core measure, counted as one of the 4. It must be designated as a core measure for the MVP you selected. |
| No applicable core measure | Attest that none is available, then report another measure in its place | Same |
| Small practice | Exempt from the requirement and the attestation | Same |
| Core measure neither reported nor attested | 0 of 10 points for one required measure | Same |
Two points are easy to miss. The small practice exemption removes the core measure requirement and its attestation only. Small practices still report the full number of quality measures. And missing the core measure does not zero out the Quality category: the penalty applies to one required measure.
CMS also changed scoring for topped-out core measures. A core measure that is topped out for two or more consecutive performance periods, and would otherwise be capped at 7 points, is now scored under the defined topped-out measure benchmark with a 10-point maximum. This applies only to core measures that meet that condition, not to every core measure. Separately, QCDRs and qualified registries must be able to submit at least six quality measures, including at least one core measure, beginning with the 2027 performance period.
Traditional MIPS Transition Through 2030
Traditional MIPS has not ended. CMS finalized its sunset after the CY 2030 performance period (2032 payment year). Beginning with CY 2031 (2033 payment year), MVPs become the only MIPS reporting option for clinicians who are not in a MIPS APM. Clinicians in a MIPS APM can continue to report the APM Performance Pathway.
| Performance year | Traditional MIPS | MVP reporting |
| 2027 | Available | Optional |
| 2028 | Available | Optional |
| 2029 | Available | Optional. Virtual groups can report MVPs for the first time. |
| 2030 | Available (final year) | Optional |
| 2031 | No longer available | Required for clinicians not eligible for the APM Performance Pathway |
CMS says the extra two years are meant to let clinicians identify the right MVP, build workflows around its measures and activities, and set up data collection at the subgroup level where applicable.
2027 MIPS Value Pathway Requirements
Eligibility, reporting entities, and performance periods continue under the existing framework, with the 2027 changes layered on top. This table is a map; each row points to the section that explains it. For eligibility rules, deadlines, and program-wide requirements, see our 2027 MIPS reporting requirements guide.
| Requirement | What to know for 2027 |
| Eligibility | Clinician type, Medicare billing volume, and APM status decide participation. Verify each clinician on the QPP participation lookup. |
| MVP selection | Register in advance for one pathway. Review all 30 (see the full inventory below). |
| Quality | Four measures from the pathway, including at least one core measure unless exempt or properly attested. |
| Cost | CMS calculates the pathway’s cost measures from Medicare claims. You submit nothing. |
| Improvement Activities | One activity from the pathway, performed for at least 90 continuous days. Confirm in the 2027 MVPs Implementation Guide. |
| Promoting Interoperability | Certified EHR technology and the required measures over a continuous 180-day period, with exclusions and reweighting for some clinicians. |
| Data submission | Through an approved method such as a QCDR or qualified registry. Confirm your vendor supports the pathway. |
| Final score | Four categories, default weights of 30%, 30%, 15%, and 25%. |
Registration and Participation
To report an MVP, you must register in advance on the QPP website. Registration requires the QPP Security Official role for the practice (TIN) or APM Entity. CMS also published a small practice checklist for getting started with MVP reporting on November 10, 2026, in the QPP Resource Library.
For the 2026 performance year, CMS’s registration guide shows a window from April 1 through November 30, 2026 at 8 p.m. ET, with a June 30 deadline to register for the CAHPS for MIPS Survey. Some third-party pages list December 1, so use the QPP site as the authority. CMS had not announced the 2027 registration window when this article was last reviewed, and it should not be assumed to match 2026.
Before you register, settle these points:
- The reporting entity (individual, group, subgroup, or APM Entity)
- The pathway you selected
- Which clinicians are included
- Whether your registry or QCDR supports the pathway
CMS’s 2026 data submission window runs from January 4 through March 31, 2027. Confirm the applicable submission requirements and dates through the QPP website. The 2027 performance-year submission window is expected to take place in early 2028, but CMS has not confirmed its exact dates.
Scoring and Payment Adjustments
Performance in 2027 affects Medicare payment in the 2029 payment year. The default category weights are the same as in 2026.
| Performance category | Weight |
| Quality | 30% |
| Cost | 30% |
| Improvement Activities | 15% |
| Promoting Interoperability | 25% |
| Total | 100% |
The performance threshold is the score CMS compares your final score against. It is 75 points through the CY 2028 performance period. Reaching 75 avoids a penalty, but it does not earn a bonus.The scale below follows the payment adjustment formula in the MIPS regulations and CMS’s published adjustment tables.
| Final score | Payment adjustment |
| 0 to 18.75 | -9% |
| 18.76 to 74.99 | Negative adjustment between -9% and 0% |
| 75.00 | Neutral (0%) |
| 75.01 to 100 | Positive adjustment, subject to a scaling factor for budget neutrality |
The -9% maximum negative adjustment is set by law under MACRA. Positive adjustments are not fixed percentages. CMS applies a scaling factor to keep the program budget neutral, so a higher score does not guarantee a specific payment increase. Your final score and your payment adjustment are two different numbers.
The default weights do not apply to everyone. CMS can reweight categories for extreme and uncontrollable circumstances, approved hardship exceptions, special reporting circumstances, and cases where a third-party intermediary fails to submit a clinician’s data. For intermediary failures, CMS finalized an extension of the deadline to notify CMS from November 1 to December 31 of the data submission year, beginning with the CY 2025 performance period (2027 payment year).
All 30 MIPS Value Pathways for 2027
The pathway names below match the 2027 Finalized MVPs Guide, and the MVP IDs come from CMS’s final rule fact sheet (Appendix H). The grouping column is our own editorial grouping for orientation. It is not a CMS category and does not tell you which specialties a pathway suits. CMS lists the specialties most applicable to each pathway in the guide and on its Explore MVPs page, and the pathway specification is the authority.
The three new pathways are Diabetic Disease, Hypertension, and Hospitalist. CMS modified all 27 existing pathways to identify core measures, add measures, and remove measures and activities that are being retired. It also renamed Rehabilitative Support for Musculoskeletal Care to Rehabilitative Support.
| # | Official MVP name | MVP ID | Editorial grouping | 2027 status |
| 1 | Adopting Best Practices and Promoting Patient Safety within Emergency Medicine | G0057 | Hospital-based, emergency, anesthesia, diagnostic | Modified |
| 2 | Advancing Cancer Care | M0001 | Medical specialties and cancer | Modified |
| 3 | Advancing Care for Heart Disease | G0055 | Cardiovascular, neurological, pulmonary | Modified |
| 4 | Advancing Rheumatology Patient Care | G0053 | Medical specialties and cancer | Modified |
| 5 | Complete Ophthalmologic Care | M1420 | Medical specialties and cancer | Modified |
| 6 | Coordinating Stroke Care to Promote Prevention and Cultivate Positive Outcomes | G0054 | Cardiovascular, neurological, pulmonary | Modified |
| 7 | Dermatological Care | M1421 | Medical specialties and cancer | Modified |
| 8 | Diabetic Disease | M1504 | Primary care and chronic disease | New |
| 9 | Diagnostic Radiology | M1498 | Hospital-based, emergency, anesthesia, diagnostic | Modified |
| 10 | Focusing on Women’s Health | M1366 | Primary care and chronic disease | Modified |
| 11 | Gastroenterology Care | M1422 | Medical specialties and cancer | Modified |
| 12 | Hospitalist | M1505 | Hospital-based, emergency, anesthesia, diagnostic | New |
| 13 | Hypertension | M1506 | Primary care and chronic disease | New |
| 14 | Improving Care for Lower Extremity Joint Repair | G0058 | Surgical, musculoskeletal, rehabilitative | Modified |
| 15 | Interventional Radiology | M1499 | Hospital-based, emergency, anesthesia, diagnostic | Modified |
| 16 | Neuropsychology | M1500 | Cardiovascular, neurological, pulmonary | Modified |
| 17 | Optimal Care for Kidney Health | M0002 | Primary care and chronic disease | Modified |
| 18 | Optimal Care for Patients with Urologic Conditions | M1423 | Medical specialties and cancer | Modified |
| 19 | Pathology | M1501 | Hospital-based, emergency, anesthesia, diagnostic | Modified |
| 20 | Patient Safety and Support of Positive Experiences with Anesthesia | G0059 | Hospital-based, emergency, anesthesia, diagnostic | Modified |
| 21 | Podiatry | M1502 | Surgical, musculoskeletal, rehabilitative | Modified |
| 22 | Prevention and Treatment of Infectious Disorders Including Hepatitis C and HIV | M1368 | Primary care and chronic disease | Modified |
| 23 | Pulmonology Care | M1424 | Cardiovascular, neurological, pulmonary | Modified |
| 24 | Quality Care for Patients with Neurological Conditions | M0004 | Cardiovascular, neurological, pulmonary | Modified |
| 25 | Quality Care for the Treatment of Ear, Nose, and Throat Disorders | M1367 | Medical specialties and cancer | Modified |
| 26 | Quality Care in Mental Health and Substance Use Disorders | M1369 | Medical specialties and cancer | Modified |
| 27 | Rehabilitative Support | M1370 | Surgical, musculoskeletal, rehabilitative | Renamed (formerly Rehabilitative Support for Musculoskeletal Care) |
| 28 | Surgical Care | M1425 | Surgical, musculoskeletal, rehabilitative | Modified |
| 29 | Value in Primary Care | M0005 | Primary care and chronic disease | Modified |
| 30 | Vascular Surgery | M1503 | Surgical, musculoskeletal, rehabilitative | Modified |
CMS’s Appendix H labels the new pathway “Diabetes” while its FAQ list says “Diabetic Disease.” We use the FAQ name. The 2027 Finalized MVPs Guide now provides the quality measures, core measure designations, cost measures, and Improvement Activities associated with each pathway. Practices should review the relevant pathway specifications before registering and confirm that their reporting vendor supports the required measures and data collection methods.
A name can mislead. There is no pathway named for pain management among the 30, so a pain management practice has to test candidate pathways against its actual patients and services rather than assume one exists. Our pain management MIPS reporting guide walks through that evaluation.
How to Select the Right MVP for Your Medical Practice
Match the pathway to the care you actually deliver, not to the title that sounds closest. A workable sequence:
- Settle who is reporting. Individual, group, and subgroup reporting open different doors, and a multispecialty group may need a different pathway for each subgroup. Decide the reporting level before you compare pathways.
- Profile your volume. List the diagnoses and procedures that make up most of your visits. Note your Medicare volume separately, because CMS builds cost measures from Medicare claims.
- Shortlist from all 30 pathways. Do not stop at last year’s choice or the title closest to your specialty. Read the specialties CMS lists as most applicable for each pathway you consider.
- Test measure applicability. You need four measures you can report accurately. If a pathway leaves you stretching to find them, treat that as a warning sign.
- Check the core measure. Confirm that at least one core measure in the pathway fits your patients, or note that you are a small practice, or decide whether an attestation is genuinely justified.
- Check Improvement Activity feasibility. Choose an activity your team can perform for at least 90 continuous days and document.
- Check Promoting Interoperability readiness. Confirm EHR certification and any exclusions you may claim.
- Check cost exposure. Find out which cost measures attach to the pathway and whether your attributed Medicare volume is likely to trigger them.
- Check vendor support. Confirm that your registry, QCDR, or EHR vendor supports the pathway, particularly a new one.
- Record the decision. Write down who owns reporting, how often performance is reviewed, and why you chose this pathway over the others.
A Practical MVP Selection Scorecard
Score each shortlisted pathway against the same questions. This is a practical aid, not a CMS tool.
| Criterion | Question to ask | Good sign | Warning sign |
| Patient fit | Do most of our patients fall into the measures’ denominators? | Several measures apply to a large share of volume | Only one or two measures apply, and only to a few patients |
| Core measure | Is there a core measure we can report accurately? | A core measure matches a common service | The only core options match services we barely provide |
| Data capture | Is the data in structured EHR fields? | Capture already happens at the visit | Data lives in free text or on paper |
| Improvement Activity | Can we perform and document it for 90 days? | A clear owner and evidence trail | Nobody owns it |
| Cost | Which cost measures attach, and will we be attributed cases? | Care patterns we understand and monitor | Unfamiliar episodes we cannot influence |
| Vendor | Does our registry or EHR support it now? | Confirmed in writing | Roadmap promises only |
| Capacity | Can staff track it all year? | Named owner and quarterly review | Reporting treated as a year-end task |
An illustrative example
This example is hypothetical and is not a CMS rule. An orthopedic group sees joint replacement, sports injuries, and post-operative rehabilitation. Three pathways look plausible: Improving Care for Lower Extremity Joint Repair, Surgical Care, and Rehabilitative Support. The group pulls a year of its own data and tests each one.
| Test | Lower Extremity Joint Repair | Surgical Care | Rehabilitative Support |
| Patients covered by usable measures | Few, because most patients are not joint replacement cases | Most | Some, mainly the post-operative group |
| Core measure available and reportable | Yes, but it applies to a small group | Yes, and it applies to common procedures | Depends on whether functional outcome tools are in use |
| Improvement Activity | Doable | Doable | Doable |
| Registry support confirmed | Yes | Yes | Not yet confirmed |
On these made-up results, Surgical Care covers the most patients despite the less specific name. The group would still check each measure’s applicability against the specification, because CMS does not list orthopedic surgery among that pathway’s specialties. The deciding factor was applicability to real patients, not the title.
Individual, Group, Subgroup, and Virtual Group Reporting
- Individual clinicians can register for and report an MVP. Scoring uses that clinician’s data.
- Single-specialty groups can report as a group. CMS defines this as clinicians in one specialty type or involved in a single focus of care, and groups attest to their composition during registration.
- Small multispecialty groups (a TIN with 15 or fewer clinicians) can report as a group, or form subgroups if they prefer.
- Larger multispecialty groups cannot report an MVP as one group. They report through subgroups or as individuals. This has applied since the 2026 performance year.
- Subgroups let clinicians within a group report the pathway that matches their work. Each needs data collection and attribution set up at the subgroup level.
- APM Entities can report MVPs, and clinicians in a MIPS APM can continue to use the APM Performance Pathway.
- Virtual groups cannot report MVPs until the CY 2029 performance period. A virtual group is a different reporting structure from a subgroup. The 2029 date applies specifically to virtual group participation in MVP reporting. It does not delay subgroup reporting, which is already available under the MVP framework. Do not treat virtual groups and subgroups as interchangeable.
Eligibility and registration steps differ by entity, so confirm yours on the QPP website before you commit.
Understanding the Four MIPS Performance Categories Under MVP Reporting
An MVP ties the four categories to one clinical theme, but each keeps its own rules.
Quality. You report four measures from the pathway and collect data for the full year. The pathway’s list is a subset of the full inventory, so a measure you used before may not be in it. The core measure rules are covered above.
Cost. You submit nothing. CMS calculates cost measures from Medicare claims, and for an MVP only the measures linked to your pathway count. Not every practice has enough attributed cases to be scored on every measure. CMS finalized no cost measure inventory updates for 2027, so review the cost measures attached to your pathway rather than assuming your 2026 experience carries over.
Improvement Activities. An MVP reporter performs one activity from the pathway for at least 90 continuous days. Keep dates, responsible staff, and evidence. For 2027, CMS added six activities, modified five, and removed 11, including IA_CC_12 and IA_BE_15, so check your plan against the current inventory. The six new activities are:
- Use of Data to Improve Practice Workflows
- Understand and Improve Diagnostic Performance
- Systematic Screening and Intervention for Nutrition and other Health-Impacting, Non-Clinical Issues
- Advance Care Planning Conversations to Support Patient Wellness and Care Preferences
- Clinician Use of Artificial Intelligence (AI) to Improve Patient Care
- Lifestyle Approaches to Diabetes Remediation
Promoting Interoperability. This category relies on certified EHR technology and a required measure set over a continuous 180-day period, with exclusions and reweighting for some clinicians. The 2027 changes are:
- The Security Risk Analysis measure is removed starting with the 2027 performance period.
- Electronic Prior Authorization is optional in 2027, worth 10 bonus points, and becomes required in 2028.
- A new Electronic Prior Authorization for Prescription Drugs measure becomes required in 2028.
- The ONC Direct Review and ONC-ACB Surveillance attestations are removed starting with the 2026 performance period, so they should not be included in 2026 data submitted in early 2027.
| Important compliance distinction: Removing the Security Risk Analysis measure from MIPS Promoting Interoperability does not remove the HIPAA Security Rule obligation to conduct an accurate and thorough risk analysis of risks and vulnerabilities to electronic protected health information. That obligation comes from HHS and remains separate from CMS’s MIPS reporting requirements. Practices should keep HIPAA risk analysis and remediation activities on their compliance calendar even though the MIPS measure has been removed.Ask your EHR vendor about its prior authorization roadmap now, since the 2028 requirement depends on certified technology. |
2027 MVP Quality Measures and Specialty-Specific Reporting
CMS finalized 180 quality measures for 2027, down from 190 in 2026, with QCDR measures excluded from both totals. The changes behind that number are 2 added measures (one delayed to 2028), 4 QCDR measures adopted as MIPS CQMs, 5 functional outcome measures that replace 7 existing ones, 20 removals, and substantive changes to 43 measures. An MVP draws from a defined subset of this inventory, which is why a practice can see a measure in the full list and then find it missing from its pathway. CMS identifies core measures in Appendix H of its final rule fact sheet and in each pathway’s specification.
Specialty examples show how this works, though none replaces reading the specification:
- Orthopedic and rehabilitation care. The five new functional improvement measures (Q518 to Q522) cover neck, upper extremity, back, lower extremity, and knee impairments, and they replace the seven functional status measures CMS removed. In the Improving Care for Lower Extremity Joint Repair pathway, CMS designated Q351, Q470, and Q480 as core measures. Our orthopedic surgery MIPS reporting guide covers the specialty in more detail.
- Behavioral health. The Quality Care in Mental Health and Substance Use Disorders pathway has core designations for measures on substance use disorder treatment engagement (Q305), depression remission at twelve months (Q370), and adherence to antipsychotic medications for schizophrenia (Q383). See our mental health MIPS reporting guide for how those fit a behavioral health practice.
- Pain-related care. Pain measures appear inside pathways built around other themes. Multimodal Pain Management (Q477) is a core measure in the anesthesia pathway, and Oncology: Plan of Care for Pain (Q144) is a core measure in Advancing Cancer Care. That does not make either pathway a fit for a pain management practice, which still has to test applicability against its own patients.
MIPS Value Pathways vs Traditional MIPS in 2027
| Comparison area | Traditional MIPS | MIPS Value Pathways |
| Reporting structure | Four categories reported separately | Four categories tied to one clinical theme |
| Quality measure selection | Six measures from the broad inventory | Four measures from the pathway |
| Clinical focus | Set by your own measure choices | Set by the pathway |
| Improvement Activities | Chosen from the full inventory | Chosen from the pathway |
| Promoting Interoperability | Standard requirements | Standard requirements |
| Cost category | CMS calculates cost measures | Limited to cost measures attached to the pathway |
| Specialty alignment | Depends on your selections | Built into the pathway |
| Reporting flexibility | High | More structured, with subgroup options |
| Data collection | Flexible, more measure options | Narrower, needs pathway-specific tracking |
| Practice considerations | Familiar, but ends after the CY 2030 performance period | New workflows and the direction CMS is heading |
Neither option is better for everyone. A practice with a clean fit to a pathway may find MVPs simpler. A practice with unusual services may prefer the flexibility of traditional MIPS for now. The core measure requirement applies to both, so it does not decide the question. Our comparison of traditional MIPS vs MVPs goes deeper. Traditional MIPS has not ended. The time before 2031 is best spent on a trial run with real data, not on waiting.
Documentation and Data Collection Requirements for MVP Reporting
Reliable reporting depends on records that reflect real patient care. Plan for each of these:
- Clinical documentation that supports each measure’s numerator and denominator.
- Patient eligibility rules, including age, diagnosis, encounter type, and timing.
- Running numerator and denominator counts tracked through the year, not only at submission.
- Exclusions and exceptions documented with the clinical reason.
- Structured EHR fields. Free-text notes often do not feed reports.
- Improvement Activity evidence with dates, staff, and materials.
- Promoting Interoperability records, including exclusions claimed.
- Data validation checks for missing fields, duplicates, and implausible values.
- Submission records and an internal audit trail showing who changed what and when.
Clinicians document, billing staff code, and quality staff report. When each group works from different assumptions, gaps appear, and a short monthly review of measure performance catches them early. Documentation must reflect care that was actually delivered. It should never be fabricated, backdated, or altered to create the appearance of compliance.
Common MVP Reporting Challenges and Mistakes
| Mistake | Prevention |
| Selecting an MVP without reading the specification | Review the measures, activities, and cost measures before registering. |
| Confusing an MVP with a specialty measure set | Remember that an MVP spans four categories and requires registration. |
| Using an outdated measure inventory | Start from the 2027 specifications. The inventory shrank from 190 to 180 measures. |
| Overlooking measure applicability | Run last year’s patient data against each candidate measure. |
| Misunderstanding cost measures | Learn which cost measures attach to the pathway, even though you submit nothing. |
| Missing Improvement Activity documentation | Assign an owner and save evidence as the activity runs. |
| Overlooking Promoting Interoperability | Name an owner, confirm the period, and note the Security Risk Analysis and prior authorization changes. |
| Failing to verify eligibility | Check the QPP lookup for each clinician every year. |
| Misunderstanding subgroup reporting | Confirm registration, data collection, and attribution rules before forming one. |
| Treating the core measure as a formality | Find out early whether a core measure fits your patients, because skipping it without an attestation costs you the points on one measure. |
| Waiting until year end to validate data | Review performance at least quarterly. |
How Healthcare Practices Can Prepare for 2027 MVP Reporting
The 2027 performance year opens on January 1, so the work splits naturally into three phases. Nothing below is a CMS requirement. It is a practical order of operations built on the finalized rules.
Phase 1: Before the year opens (now through December)
- Confirm MIPS eligibility for every clinician. Check each NPI and TIN on the QPP participation lookup, and note anyone in an APM, since APM status changes which reporting option applies.
- Review the finalized 2027 MVP inventory, including the three new pathways. Read the official names and CMS’s list of most applicable specialties for any pathway you consider.
- Identify suitable pathways by mapping your services to the list. Start from your top diagnoses and procedures by volume, then shortlist two or three pathways. Do not shortlist by name alone.
- Review measure specifications and core measure options. For each shortlisted pathway, read the quality measure specifications and note which measures carry the core designation. If you are a small practice, record that you are exempt. If you are not and no core measure looks workable, document why before you consider the attestation.
- Evaluate clinical applicability using last year’s data. Run a recent year of patient data against each candidate measure and count how many patients land in the denominator. A measure with almost no eligible patients is a poor choice.
- Confirm reporting entity options and registration steps. Decide whether you will report as an individual, a group, or a subgroup. Make sure someone in your practice holds the QPP Security Official role, because registration requires it. For 2026 the registration window ran April 1 through November 30, and CMS has not yet posted 2027 dates, so confirm on QPP when they appear.
Phase 2: Build the workflow (first quarter of 2027)
- Assess quality data collection in your EHR and registry. Find where each data point lives, who captures it, and whether it sits in a structured field. Ask your registry or QCDR whether it supports your pathway, especially a new one, since vendors may not support a newly created MVP right away. CMS now requires registries and QCDRs to support at least six quality measures including one core measure.
- Review the cost measures attached to the pathway. You submit nothing for cost, but you can read CMS’s cost feedback when it is available and look at care coordination and follow-up patterns that may affect spending.
- Plan Improvement Activities and assign an owner. Pick an activity from the pathway that your team can actually perform for at least 90 continuous days, and confirm it is still in the 2027 inventory, since CMS removed 11 activities. Decide now what evidence you will save.
- Verify Promoting Interoperability requirements, including EHR certification and exclusions. Confirm that your certified EHR supports the required measures, and update your attestation workflow now that the Security Risk Analysis measure is gone. Ask your EHR vendor about its Electronic Prior Authorization plans, since that measure is optional bonus credit in 2027 and required from 2028.
- Assign reporting responsibilities across clinical, billing, and quality staff. Clinicians own documentation, billing and coding staff own accurate encounter data, and a named quality lead owns measure tracking and submission. A shared owner for each category is better than a shared inbox.
Phase 3: Monitor, validate, and submit (rest of 2027 and early 2028)
- Monitor performance each quarter. Review numerator and denominator counts, data completeness, and exclusions. Add Improvement Activity progress and Promoting Interoperability documentation to the same review.
- Validate data before submission. Check for missing fields, duplicate encounters, and implausible results, and confirm the right clinicians are tied to the right TIN, group, or subgroup. For reference, CMS’s 2026 data submission window runs January 4 through March 31, 2027, and the 2027 window should follow a similar pattern, but confirm the dates on QPP.
- Retain supporting documentation. Keep submission confirmations, activity evidence, and the record of why you chose each measure and pathway, with an audit trail of who changed what.
Who owns what
| Team | Main responsibility |
| Clinicians | Accurate, structured documentation at the point of care. Performing the Improvement Activity. |
| Billing and coding staff | Correct encounter, diagnosis, and procedure data that feeds eligibility and measure counts. |
| Quality or reporting lead | Pathway choice, measure tracking, quarterly reviews, registration, and submission. |
| EHR and IT vendor | Structured fields, certified technology, registry connection, and the prior authorization roadmap. |
| Compliance | Documentation standards, audit trail, and HIPAA obligations that sit outside MIPS. |
If you report traditional MIPS in 2026, treat that submission as a rehearsal. The same data pull that feeds your 2026 submission shows which measures your EHR captures cleanly, and that is the best evidence for choosing a 2027 pathway.
Early planning matters because a gap is cheapest to fix while the year is open. A documentation habit that is missing in March can be corrected for the remaining nine months. The same gap found at submission time cannot be fixed at all. Practices that wait also risk finding out late that their registry does not yet support the pathway they want.
How Proactive Healthcare Services Supports MIPS Reporting
Proactive Healthcare Services is a healthcare consulting, compliance, and billing support provider. For MIPS, we can help practices review eligibility, evaluate which pathway suits their patients and services, assess applicable quality measures against their documentation, organize reporting records, identify gaps before submission, coordinate the reporting workflow, and prepare data for submission. Related services include medical billing, revenue cycle management, HIPAA Security Risk Analysis, and provider credentialing.
We cannot influence how CMS scores a submission, and we do not guarantee a score, a payment adjustment, or a successful submission. Our role is to help your team make informed decisions and keep clean records.
| Preparing your practice for 2027 MIPS Value Pathways reporting? Contact Proactive Healthcare Services to discuss your reporting requirements, review your documentation workflow, and plan the next steps. Explore MIPS Value Pathways | Contact our team. |
Frequently Asked Questions
1. What are MIPS Value Pathways in 2027, and which are available?
They are a MIPS reporting option that groups quality measures, Improvement Activities, Promoting Interoperability requirements, and cost measures around a specialty, condition, or population. CMS lists 30 pathways for 2027: the 27 pathways from 2026, updated, plus Diabetic Disease, Hypertension, and Hospitalist. The full list appears above.
2. What are the major changes to MVP reporting for 2027?
CMS added three MVPs, modified all 27 existing ones to include core measures, renamed Rehabilitative Support for Musculoskeletal Care to Rehabilitative Support, replaced the outcome and high-priority requirement with a core measure requirement, and finalized six new Improvement Activities. It also set the end of traditional MIPS after the CY 2030 performance period.
3. Are MIPS Value Pathways mandatory in 2027?
No. MVPs stay optional through the CY 2030 performance period. They become required beginning with CY 2031 for clinicians who are not in a MIPS APM.
4. How do core measures affect MVP reporting?
One of your four quality measures must be a core measure designated for your pathway, with exceptions for small practices and for participants who attest that none applies. The core measure section above has the details.
5. How do providers select an MVP?
Compare each pathway’s measures, activities, and cost measures with the services you provide, test measure applicability with your own data, and confirm that your registry and EHR can support reporting.
6. Can group practices and subgroups participate in MVP reporting?
Yes. Single-specialty groups can report as a group, while larger multispecialty groups must use subgroups or report as individuals. Subgroups can participate in MVP reporting before 2029. Virtual groups, which are a separate reporting arrangement, become eligible to report MVPs beginning with the CY 2029 performance period.
7. What is the difference between traditional MIPS and MVPs?
Traditional MIPS lets you choose measures and activities independently. MVPs give you a defined set organized around a clinical theme, with four quality measures instead of six.
8. How can a medical practice prepare for 2027 MVP reporting?
Confirm eligibility, read the 2027 Finalized MVPs Guide, test measure applicability against real patient data, choose a reporting entity, register, and validate data throughout the year.
Conclusion: Preparing for MIPS Value Pathways in 2027
MIPS Value Pathways in 2027 bring a 30-pathway inventory, a new core measure requirement, changes to Promoting Interoperability, and two more years before traditional MIPS ends. The practices that do best will review the official inventory, confirm eligibility, test measure applicability against real patients, understand their reporting options, and keep documentation that reflects the care they deliver. For hands-on planning and submission support, see PHCSS MIPS reporting services.

